Combinatorial Therapies to Overcome B-Raf Inhibitor Resistance in Melanomas

Pharmacogenomics - United Kingdom
doi 10.2217/pgs.11.166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Frontiers in Oncology
Cancer ResearchOncology
2013English

MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

Β-Lactamase Inhibitor NXL104 Helps Overcome Resistance of Pathogens

Microbe
Microbiology
2011English

Antibacterial Prodrugs to Overcome Bacterial Resistance

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Recent Tools to Overcome Antibacterial Resistance

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2019English

Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells

Carcinogenesis
MedicineCancer Research
2014English

Activation Loop Phosphorylation Regulates B-Raf in Vivo and Transformation by B-Raf Mutants

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2015English

FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy